Complete Heart Block Secondary To Leptospirosis: A Case Report
Main Article Content
Abstract
Complete heart block (CHB) is a rare but potentially life-threatening complication of leptospirosis, a zoonotic bacterial infection caused by spirochetes of the genus Leptospira. While leptospirosis primarily affects the kidneys and liver, cardiac involvement, including CHB, can occur and has significant clinical implications. The pathogenesis of CHB in leptospirosis is multifactorial and may involve direct cardiac invasion by Leptospira organisms, systemic inflammatory response, autoimmune reactions, electrolyte imbalances, and hemodynamic effects. Prompt recognition and management of CHB are essential to prevent adverse outcomes, including hemodynamic instability and sudden cardiac death. Treatment strategies include supportive measures such as hemodynamic support and correction of electrolyte imbalances, temporary pacing for symptomatic bradycardia, antibiotic therapy for the underlying infection, and consideration of permanent pacemaker implantation in refractory cases. Cardiac manifestations may include myocarditis, pericarditis, arrhythmias, conduction blocks and cardiac failure. We are reporting a case of leptospirosis causing complete heart block in a previously healthy young gentleman.
Downloads
Article Details
Copyright (c) 2024 Muhammad Syafiq bin Mohammad Isa, Wan Ahmad Syahril Rozli Wan Ali
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
References
Rajiv, C., Manjuran, R. J., Sudhayakumar, N., & Haneef, M. (1996). Cardiovascular involvement in leptospirosis. Indian heart journal, 48(6), 691–694.
Kobayashi Y. (2001). Discovery of the causative organism of Weil's disease: historical view. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 7(1), 10–15. https://doi.org/10.1007/s101560170028 DOI: https://doi.org/10.1007/s101560170028
Dupouey, J., Faucher, B., Edouard, S., Richet, H., Kodjo, A., Drancourt, M., & Davoust, B. (2014). Human leptospirosis: an emerging risk in Europe?. Comparative immunology, microbiology and infectious diseases, 37(2), 77–83. https://doi.org/10.1016/j.cimid.2013.12.002 DOI: https://doi.org/10.1016/j.cimid.2013.12.002
Bandara, K., Weerasekera, M. M., Gunasekara, C., Ranasinghe, N., Marasinghe, C., & Fernando, N. (2016). Utility of modified Faine's criteria in diagnosis of leptospirosis. BMC infectious diseases, 16(1), 446. https://doi.org/10.1186/s12879-016-1791-9 DOI: https://doi.org/10.1186/s12879-016-1791-9
Trivedi, S. V., Bhattacharya, A., Amichandwala, K., & Jakkamsetti, V. (2003). Evaluation of cardiovascular status in severe leptospirosis. The Journal of the Association of Physicians of India, 51, 951–953.
Navinan, M. R., & Rajapakse, S. (2012). Cardiac involvement in leptospirosis. Transactions of the Royal Society of Tropical Medicine and Hygiene, 106(9), 515–520. https://doi.org/10.1016/j.trstmh.2012.06.007 DOI: https://doi.org/10.1016/j.trstmh.2012.06.007